Mesenchymal stem cells-derived small extracellular vesicles and apoptotic extracellular vesicles for wound healing and skin regeneration: a systematic review and meta-analysis of preclinical studies
Open Access
- 24 March 2025
- journal article
- review article
- Published by Springer Nature in Journal of Translational Medicine
- Vol. 23 (1) , 1-21
Abstract
Studies examining the therapeutic potential of Mesenchymal stem cells-derived extracellular vesicles (MSC-EVs) in wound healing and skin regeneration have progressed rapidly. Prior to considering clinical translation, a systematic and comprehensive understanding of these experimental details and the overall impact of MSC-EVs on skin regeneration is necessary. 83 studies were identified in Web of Science, Embase, and PubMed that satisfied a set of prespecified inclusion criteria. A random effects meta-analysis was conducted for wound closure rate, scar width, blood vessel density and collagen deposition. Our findings demonstrate clear potential of MSC-EVs to be developed as therapy for wound healing and skin regeneration both in diabetic and non-diabetic animal models. Moreover, subgroup analyses demonstrated that apoptotic small extracellular vesicles (ApoSEVs) showed better efficacy than apoptotic bodies (ApoBDs) and small extracellular vesicles (sEVs) in wound closure outcome and collagen deposition, while sEVs displayed better than ApoEVs in revascularization. Among frequently used routes of administration, subcutaneous injection displayed a greater improvement to wound closure, collagen deposition and revascularization as compared to dressing/covering. Among easier-access source of MSCs, ADSCs demonstrated the best effect in wound closure rate and collagen deposition, as compared, BMMSCs displayed better in revascularization. Additionally, high heterogeneity observed in collection conditions, separation methods, storage methods, modifications, treatment dose, administration route, and frequency of MSC-EVs underscores the urgent need for standardization in these areas, prior to clinical translation. PROSPERO CRD42024499172.Keywords
Funding Information
- National Natural Science Foundation of China (82202476, 81971852)
This publication has 94 references indexed in Scilit:
- Mesenchymal Stromal Cell Therapeutic Delivery: Translational Challenges to Clinical ApplicationFrontiers in Immunology, 2019
- Mature osteoclast–derived apoptotic bodies promote osteogenic differentiation via RANKL-mediated reverse signalingJournal of Biological Chemistry, 2019
- Promising effects of exosomes isolated from menstrual blood‐derived mesenchymal stem cell on wound‐healing process in diabetic mouse modelJournal of Tissue Engineering and Regenerative Medicine, 2019
- Engineering Bioactive Self-Healing Antibacterial Exosomes Hydrogel for Promoting Chronic Diabetic Wound Healing and Complete Skin RegenerationTheranostics, 2019
- Apoptotic Cell-Derived Extracellular Vesicles: More Than Just DebrisFrontiers in Immunology, 2018
- Concise Review: Developing Best-Practice Models for the Therapeutic Use of Extracellular VesiclesStem Cells Translational Medicine, 2017
- Exosomes derived from human amniotic epithelial cells accelerate wound healing and inhibit scar formationJournal of Molecular Histology, 2017
- Fabrication of hydroxyapatite/chitosan composite hydrogels loaded with exosomes derived from miR-126-3p overexpressed synovial mesenchymal stem cells for diabetic chronic wound healingJournal of Materials Chemistry B, 2016
- Exosome Derived From Human Umbilical Cord Mesenchymal Stem Cell Mediates MiR-181c Attenuating Burn-induced Excessive InflammationEBioMedicine, 2016
- Minimal criteria for defining multipotent mesenchymal stromal cells. The International Society for Cellular Therapy position statementCytotherapy, 2006